Decreased quality of care for Staphylococcus aureus bacteremia during the COVID-19 pandemic
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61383082%3A_____%2F22%3A00001212" target="_blank" >RIV/61383082:_____/22:00001212 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/00216208:11110/22:10445389
Výsledek na webu
<a href="https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-022-07607-9" target="_blank" >https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-022-07607-9</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1186/s12879-022-07607-9" target="_blank" >10.1186/s12879-022-07607-9</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Decreased quality of care for Staphylococcus aureus bacteremia during the COVID-19 pandemic
Popis výsledku v původním jazyce
Objectives Staphylococcus aureus bacteremia (SAB) is one of the most frequent bloodstream infections. High mortality of SAB can be significantly reduced by regular infectious disease (ID) consultations and appropriate clinical management. Because the pandemic of coronavirus disease 2019 (COVID-19) has had a negative impact on hospital ID service, it can be assumed that it has also led to decreased quality of care for SAB patients. Methods This study enrolled all (n = 68) patients with proven SAB who were hospitalized in Military University Hospital, Prague, in 2019 and 2020 and the quality of care indicators for SAB patients were compared. Results A total of 33 and 35 patients with SAB were hospitalized in our hospital in 2019 and 2020, respectively. The significant difference between the pandemic year 2020 and year 2019 was in ID consultations performed (74% vs. 100%; p = 0.002) and fulfilment of all quality of care indicators (66% vs. 93%; p = 0.012). Next, higher in-hospital mortality was observed in 2020 than in 2019 (6% vs. 23%; p = 0.085). There was no significant difference in the percentages of patients with performed echocardiographic examinations (66% vs. 83%; p = 0.156) and collected follow-up blood cultures (85% vs. 94%; p = 0.428). In addition, there was no difference between the two years in the adequate antibiotic therapy, sources, and bacterial origin of SAB. Conclusions The quality of care of SAB patients significantly decreased during the COVID-19 pandemic in our institution.
Název v anglickém jazyce
Decreased quality of care for Staphylococcus aureus bacteremia during the COVID-19 pandemic
Popis výsledku anglicky
Objectives Staphylococcus aureus bacteremia (SAB) is one of the most frequent bloodstream infections. High mortality of SAB can be significantly reduced by regular infectious disease (ID) consultations and appropriate clinical management. Because the pandemic of coronavirus disease 2019 (COVID-19) has had a negative impact on hospital ID service, it can be assumed that it has also led to decreased quality of care for SAB patients. Methods This study enrolled all (n = 68) patients with proven SAB who were hospitalized in Military University Hospital, Prague, in 2019 and 2020 and the quality of care indicators for SAB patients were compared. Results A total of 33 and 35 patients with SAB were hospitalized in our hospital in 2019 and 2020, respectively. The significant difference between the pandemic year 2020 and year 2019 was in ID consultations performed (74% vs. 100%; p = 0.002) and fulfilment of all quality of care indicators (66% vs. 93%; p = 0.012). Next, higher in-hospital mortality was observed in 2020 than in 2019 (6% vs. 23%; p = 0.085). There was no significant difference in the percentages of patients with performed echocardiographic examinations (66% vs. 83%; p = 0.156) and collected follow-up blood cultures (85% vs. 94%; p = 0.428). In addition, there was no difference between the two years in the adequate antibiotic therapy, sources, and bacterial origin of SAB. Conclusions The quality of care of SAB patients significantly decreased during the COVID-19 pandemic in our institution.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
30303 - Infectious Diseases
Návaznosti výsledku
Projekt
—
Návaznosti
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2022
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
BMC INFECTIOUS DISEASES
ISSN
1471-2334
e-ISSN
—
Svazek periodika
22
Číslo periodika v rámci svazku
1
Stát vydavatele periodika
GB - Spojené království Velké Británie a Severního Irska
Počet stran výsledku
5
Strana od-do
1-5
Kód UT WoS článku
000827739600002
EID výsledku v databázi Scopus
2-s2.0-85134423743